Dry Eye Disease Treatment Devices Market - Global Dry Eye Disease Treatment Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030 - (By Type Coverage, By Cause Coverage, By Application Coverage, By End User Cover

Dry Eye Disease Treatment Devices Market - Global Dry Eye Disease Treatment Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030 - (By Type Coverage, By Cause Coverage, By Application Coverage, By End User Coverage, By Region Coverage, Leading Companies)


Dry eye disease, a common ocular condition characterised by insufficient tear production or poor tear quality, has become increasingly prevalent in recent years, primarily due to the widespread use of digital screens and an ageing population. In response to the rising demand for effective dry eye treatments, the global market for dry eye disease treatment devices is expected to witness substantial growth in the coming years.

According to a recently published report of Fairfield Market Research, the dry eye disease treatment devices market size is projected to surpass US$327.1 Mn by the end of 2030, representing a promising growth rate during the forecast period. This report provides detailed insights into the market's growth analysis and forecast for the years 2022 to 2030, shedding light on key growth indicators, major market segments, regional trends, market opportunities, and major players.

“The projected 6% CAGR from 2022 to 2030 indicates healthy potential for growth, with revenue expected to reach past US$327 Mn by the end of the forecast period. While North America leading the market due to early FDA approvals, and Asia Pacific is poised for rapid growth fuelled by medical tourism,” says the company analyst.

Market Growth Projections

As dry eye disease continues to affect a growing number of individuals, the demand for effective and innovative treatment devices is expected to surge. Advancements in technology and product development, coupled with an expanding geriatric population and excessive screen time, will be significant drivers of market growth.

Additionally, the rising prevalence of diabetes and the increasing adoption of dry eye treatment devices at eye care centres will contribute to the market's expansion. As key players continue to innovate and address the evolving needs of patients, the market is set to witness a transformative phase, offering effective solutions to the growing global burden of dry eye condition.

Segmentation Analysis

Meibomian Gland Unclogging Devices Top Selling


Among the various dry eye treatment devices, meibomian gland unclogging devices spearhead the market. These devices aid in restoring tear production by addressing meibomian gland occlusion, a common cause of dry eye condition. The consistent demand for these unclogging devices is mainly driven by optometrists, and popular products like Sight Sciences' TearCare and Johnson & Johnson Vision’s LipiFlow Thermal Pulsation System are expected to drive the growth of this segment.

Wearables Reflect High Growth Potential

Wearable devices, known for their convenience and user-friendly features, show promising growth potential. The segment's attractiveness is further enhanced by innovations in the field, including the use of contact lenses for treating corneal dryness. The report predicts a bright future for wearable devices, attributing their rising popularity to the growing demand for hassle-free and effective treatments.

Application Maximum in Evaporative Dry Eye Condition

The evaporative application segment leads in terms of revenue, primarily due to a higher prevalence of meibomian gland dysfunction (MGD), a condition commonly associated with evaporative dry eye disease.

Hospitals Account for a Lion’s Share

Hospitals currently dominate the adoption of dry eye treatment devices, contributing over 40% to the market's value. However, eye care centres are expected to witness a significant surge in adoption during the forecast period.

Regional Outlook

Faster FDA Approvals Pave the Way for North America’s Dominance


North America is expected to maintain dominance in the dry eye disease treatment devices market, with a projected CAGR of 5.5% by the end of 2030. The accelerated adoption of these devices in the region can be attributed to early approvals from the US FDA, a growing elderly patient pool, and an increasing number of smartphone users. Additionally, the higher prevalence of diabetes has also played a role in shaping the market in this region.

Asia Pacific Set for the Fastest Growth

On the other hand, Asia Pacific is expected to witness the fastest growth, with India leading the region in terms of the patient population of dry eye disease. This region is anticipated to achieve an impressive CAGR of 7.8% during the forecast period. The key position of Asia Pacific in the medical tourism industry is expected to foster market expansion in the region.

Key Market Players in Dry Eye Disease Treatment Devices

The market for dry eye disease treatment devices is moderately consolidated, with a few key players holding substantial revenue shares. Leading companies such as Alcon Vision LLC, Johnson and Johnson Services Inc., Lumenis Be Ltd, AbbVie Inc., ESW – Vision, Sight Sciences, Eyedetec Medical Inc., BlephEx, MiBo Medical Group, and NuSight Medicals- NuLids LLC are actively operating in this market.Immediate Delivery

Please note: The PDF e-mail from publisher version of this report is for a global site license.


1. Executive Summary
1.1. Global Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030 (US$ Million)
1.2. Key Industry Trends
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Market Drivers
2.2.2. Market Threats
2.2.3. Market Opportunities
2.3. Regulatory Framework
2.4. Reimbursement Scenario
2.5. LASIK and CATARACT Surgery Statistics, By Key Countries
2.6. Digital Screen Usage Statistics, By Key Countries
3. Global Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
3.1. Global Dry Eye Disease Treatment Devices Market Outlook, By Product Type, 2018 - 2030
3.1.1. Key Highlights
3.1.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
3.1.2.1. Meibomian Gland Unclogging Devices
3.1.2.2. Wearable Devices
3.1.2.3. Punctual Occlusion Devices
3.1.2.4. Pain Relieving Devices
3.1.2.5. Others
3.2. Global Dry Eye Disease Treatment Devices Market Outlook, By Cause, 2018 - 2030
3.2.1. Key Highlights
3.2.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
3.2.2.1. Idiopathic
3.2.2.2. Rare Diseases
3.2.2.3. Surgery
3.2.2.4. Drug Intake Associated
3.2.2.5. Digital Exposure
3.2.2.6. Age Related
3.3. Global Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
3.3.1. Key Highlights
3.3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
3.3.2.1. Aqueous Deficient
3.3.2.2. Evaporative
3.4. Global Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
3.4.1. Key Highlights
3.4.2. Global Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
3.4.2.1. Hospitals
3.4.2.2. Clinics
3.4.2.3. Eye Care Centres
3.4.2.4. Others
3.5. Global Dry Eye Disease Treatment Devices Market Outlook, By Region, 2018 - 2030
3.5.1. Key Highlights
3.5.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Million), 2018 - 2030
3.5.2.1. North America
3.5.2.2. Europe
3.5.2.3. Asia Pacific
3.5.2.4. Latin America
3.5.2.5. Middle East and Africa
4. North America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
4.1. North America Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
4.1.1. Key Highlights
4.1.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
4.1.2.1. U.S.
4.1.2.2. Canada
4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
4.2.1. Key Highlights
4.2.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
4.2.2.1. Meibomian Gland Unclogging Devices
4.2.2.2. Wearable Devices
4.2.2.3. Punctual Occlusion Devices
4.2.2.4. Pain Relieving Devices
4.2.2.5. Others
4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
4.3.1. Key Highlights
4.3.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
4.3.2.1. Idiopathic
4.3.2.2. Rare Diseases
4.3.2.3. Surgery
4.3.2.4. Drug Intake Associated
4.3.2.5. Digital Exposure
4.3.2.6. Age Related
4.4. North America Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
4.4.1. Key Highlights
4.4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
4.4.2.1. Aqueous Deficient
4.4.2.2. Evaporative
4.5. North America Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
4.5.1. Key Highlights
4.5.2. North America Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
4.5.2.1. Hospitals
4.5.2.2. Clinics
4.5.2.3. Eye Care Centres
4.5.2.4. Others
5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
5.1.1. Key Highlights
5.1.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
5.1.2.1. U.K.
5.1.2.2. France
5.1.2.3. Germany
5.1.2.4. Italy
5.1.2.5. Spain
5.1.2.6. Rest of Europe
5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
5.2.1. Key Highlights
5.2.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
5.2.2.1. Meibomian Gland Unclogging Devices
5.2.2.2. Wearable Devices
5.2.2.3. Punctual Occlusion Devices
5.2.2.4. Pain Relieving Devices
5.2.2.5. Others
5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
5.3.1. Key Highlights
5.3.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
5.3.2.1. Idiopathic
5.3.2.2. Rare Diseases
5.3.2.3. Surgery
5.3.2.4. Drug Intake Associated
5.3.2.5. Digital Exposure
5.3.2.6. Age Related
5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
5.4.1. Key Highlights
5.4.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
5.4.2.1. Aqueous Deficient
5.4.2.2. Evaporative
5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
5.5.1. Key Highlights
5.5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
5.5.2.1. Hospitals
5.5.2.2. Clinics
5.5.2.3. Eye Care Centres
5.5.2.4. Others
6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
6.1.1. Key Highlights
6.1.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
6.1.2.1. China
6.1.2.2. India
6.1.2.3. Japan
6.1.2.4. Indonesia
6.1.2.5. Thailand
6.1.2.6. Malaysia
6.1.2.7. Singapore
6.1.2.8. Rest of Asia Pacific
6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
6.2.1. Key Highlights
6.2.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
6.2.2.1. Meibomian Gland Unclogging Devices
6.2.2.2. Wearable Devices
6.2.2.3. Punctual Occlusion Devices
6.2.2.4. Pain Relieving Devices
6.2.2.5. Others
6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
6.3.1. Key Highlights
6.3.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
6.3.2.1. Idiopathic
6.3.2.2. Rare Diseases
6.3.2.3. Surgery
6.3.2.4. Drug Intake Associated
6.3.2.5. Digital Exposure
6.3.2.6. Age Related
6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
6.4.1. Key Highlights
6.4.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
6.4.2.1. Aqueous Deficient
6.4.2.2. Evaporative
6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
6.5.1. Key Highlights
6.5.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
6.5.2.1. Hospitals
6.5.2.2. Clinics
6.5.2.3. Eye Care Centres
6.5.2.4. Others
7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
7.1.1. Key Highlights
7.1.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
7.1.2.1. Brazil
7.1.2.2. Mexico
7.1.2.3. Rest of Latin America
7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
7.2.1. Key Highlights
7.2.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
7.2.2.1. Meibomian Gland Unclogging Devices
7.2.2.2. Wearable Devices
7.2.2.3. Punctual Occlusion Devices
7.2.2.4. Pain Relieving Devices
7.2.2.5. Others
7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
7.3.1. Key Highlights
7.3.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
7.3.2.1. Idiopathic
7.3.2.2. Rare Diseases
7.3.2.3. Surgery
7.3.2.4. Drug Intake Associated
7.3.2.5. Digital Exposure
7.3.2.6. Age Related
7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
7.4.1. Key Highlights
7.4.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
7.4.2.1. Aqueous Deficient
7.4.2.2. Evaporative
7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
7.5.1. Key Highlights
7.5.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
7.5.2.1. Hospitals
7.5.2.2. Clinics
7.5.2.3. Eye Care Centres
7.5.2.4. Others
8. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
8.1. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
8.1.1. Key Highlights
8.1.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
8.1.2.1. GCC
8.1.2.2. South Africa
8.1.2.3. Rest of Middle East and Africa
8.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
8.2.1. Key Highlights
8.2.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
8.2.2.1. Meibomian Gland Unclogging Devices
8.2.2.2. Wearable Devices
8.2.2.3. Punctual Occlusion Devices
8.2.2.4. Pain Relieving Devices
8.2.2.5. Others
8.3. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
8.3.1. Key Highlights
8.3.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
8.3.2.1. Idiopathic
8.3.2.2. Rare Diseases
8.3.2.3. Surgery
8.3.2.4. Drug Intake Associated
8.3.2.5. Digital Exposure
8.3.2.6. Age Related
8.4. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
8.4.1. Key Highlights
8.4.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
8.4.2.1. Aqueous Deficient
8.4.2.2. Evaporative
8.5. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
8.5.1. Key Highlights
8.5.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
8.5.2.1. Hospitals
8.5.2.2. Clinics
8.5.2.3. Eye Care Centres
8.5.2.4. Others
8.6. Competitive Landscape
8.6.1. Company Profiles
8.6.1.1. Alcon Vision LLC.
8.6.1.1.1. Company Overview
8.6.1.1.2. Financial Performance
8.6.1.1.3. Product Portfolio
8.6.1.1.4. Pipeline Analysis
8.6.1.2. Johnson and Johnson Services Inc.
8.6.1.3. AbbVie Inc.
8.6.1.4. Lumenis Be Ltd
8.6.1.5. ESW-Vision
8.6.1.6. Mibo Medical Group
8.6.1.7. Sight Sciences.
8.6.1.8. Eyedetect Medical Inc.
8.6.1.9. BlephEx
8.6.1.10. NuSight Medicals-Nulids LLC
8.6.1.11. Others
9. Appendix
9.1 Research Methodology
9.2 Report Specific Research Approach

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings